Список литературы

1. CDC. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae-- 2014. MMWR. Recommendations and reports: Morbidity and mortality weekly report. Recommendations and reports. Centers for Disease Control. Mar 14 2014; 63(RR-02): 1 - 19.

2. Grad A., Vica M.L., Matei H.V., Grad D.R., Coman I., and Tataru D.A. Polymerase Chain Reaction as a Diagnostic Tool for Six Sexually Transmitted Infections - Preliminary Results: Clujul Med. 2015; 88(1): 33 - 37.

3. Knox J., Tabrizi S.N., Miller P., et al. Evaluation of self-collected samples in contrast to practitioner-collected samples for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by polymerase chain reaction among women living in remote areas. Sex Transm Dis. Nov 2002; 29(11): 647 - 654.

4. Chachter J., Chernesky M.A., Willis D.E., et al. Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: Results from a multicenter evaluation of the APTIMA assays for both infections. Sex Transm Dis. Dec 2005; 32(12): 725 - 728.

5. Schachter J., Moncada J., Liska S., Shayevich C., Klausner J.D. Nucleic acid amplification tests in the diagnosis of Chlamydial and Gonococcal infections of the oropharynx and rectum in men who have sex with men. Sex Transm Dis. Jul 2008; 35(7): 637 - 642.

6. Mimiaga M.J., Mayer K.H., Reisner S.L., et al. Asymptomatic gonorrhea and chlamydial infections detected by nucleic acid amplification tests among Boston area men who have sex with men. Sex Transm Dis. May 2008; 35(5): 495 - 498.

7. Bachmann L.H., Johnson R.E., Cheng H., et al. Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatisrectal infections. J. Clin Microbiol. May 2010; 48(5): 1827 - 1832.

8. Шипицына Е.В., Шалепо К.В., Савичева А.М., Домейка М. Научные исследования по оптимизации методов лабораторной диагностики инфекций, передаваемых половым путем. Журнал акушерства и женских болезней, 2007; том LVI. N 5: с. 32 - 35.

9. Association of Public Health Laboratories (APHL). Laboratory diagnostic testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Expert consultation meeting summary report. Atlanta, GA.: Silver Spring, MD, APHL, 2009; uRLhttp://www.aphl.org/aphlprograms/infectious/std/Documents/ID_2009Jan_CTGCLab-Guidelines-Meeting-Report.pdf.

10. Horner P. et al. Enhanced enzyme immunoassay with negative-gray-zone testing compared to a single nucleic acid amplification technique for community based chlamydial screening of men. Journal of Clinical Microbiology, 2005, 43(5): 2065 - 2069.

11. Renton A., Filatova E., Ison C., Meheus A., Dmitriev G., Akovbian V., et al. A trial of the validity of genital smears and cultures with gonococcal vaccine provocation in diagnosing genital gonorrhoea in women. Int J STD AIDS 2009; 20: 24 - 29.

12. Lau C.Y., Qureshi A.K. Azithromycin versus doxycycline for genital Chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis 2002; 29: 497 - 502.

13. Hocking J., Kong F., Vodstrcil L., et al. Controlled Trials Infection - a Meta-Analysis of Randomised the Treatment of Genital Chlamydia. Sex Transm Infect 2013; 89: A30.

14. Geisler W.M., Koltun W.D., Abdelsayed N., et al. Safety and efficacy of WC2031 versus vibramycin for the treatment of uncomplicated urogenital Chlamydia trachomatis infection: a randomized, double-blind, double-dummy, active-controlled, multicenter trial. Clin Infect Dis 2012; 55: 82 - 8.

15. CDC. Sexually Transmitted Diseases Guidelines; 2014; URL:http://www.cdc.gov/std/treatment/2014/2014-std-guidelines-peer-reviewers-08-20-2014.pdf.

16. European guideline for the management of Chlamydia trachomatis infections 2015. URL http://www.iusti.org/regions/europe/pdf/2015/Chlamydia2015.pdf.

17. Adimora A.A. Treatment of uncomplicated genital Chlamydia trachomatis infections in adults. Clin Infect Dis 2002; 35: S183 - S186.

18. Schillinger J.A., Kissinger P., Calvet H., Whittington W.L., Ransom R.L., Sternberg M.R., et al. Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial. Sex Transm Dis 2003; 30: 49 - 56.

19. Dreses-Werringloer U., Padubrin I., Zeidler H., Kohler L. Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro. Antimicrob Agents Chemother 2001; 45: 3001 - 8.

20. Pitsouni E., Iavazzo C., Athanasiou S., Falagas M.E. Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta-analysis of randomised controlled trials. Int J Antimicrob Agents 2007; 30: 213 - 21.

21. Czeizel A.E., Rockenbauer M., Olsen J., Sorensen H.T. A case-control teratological study of spiramycin, roxithromycin, oleandomycin and josamycin. Acta Obstet Gynecol Scand 2000; 79: 234 - 7.

22. Iakubovich A.I., Chuprin A.E., Rakitin D.A. Urogenital chlamydia infection: treatment with wilprafen. Urologiia. 2003 Jan - Feb; (1): 55 - 8.

23. Ibsen H.H., Moller B.R., Halkier-Sorensen L., et al. Treatment of nongonococcal urethritis: comparison of ofloxacin and erythromycin. Sex Transm Dis 1989; 16: 32 - 35.

24. Maiti H., Chowdhury F.H., Richmond S.J., et al. Ofloxacin in the treatment of uncomplicated gonorrhea and chlamydial genital infection. Clin Ther 1991; 13: 441 - 447.

25. Takahashi S., Ichihara K., Hashimoto J., et al. Clinical efficacy of levofloxacin 500 mg once daily for 7 days for patients with non-gonococcal urethritis. J Infect Chemother 2011; 17: 392 - 396.

26. Khrianin A.A. and Reshetnikov O.V. Is it safe to use josamycin in the obstetrics practice in Russia?. Antibiot Khimioter 2007; 52: 32 - 36.

27. Primiero F.M., Caruso G., Grottanelli F., et al. Josamycin in the treatment of Chlamydia trachomatis cervicitis. J Chemother 1989; 1: 909 - 910.

28. Lucisano A., Vitale A.M., Cinque B., et al. Josamycin in the treatment of chlamydial genital infections in infertile women. J Chemother 1989; 1: 906 - 908.

29. Molochkov V.A., Mostakova N.N. Vilprafene (josamycin) therapy of chronic chlamydial prostatitis. Urologiia. 2001 May - Jun; (3): 34 - 5.

30. Rahangdale L., Guerry S., Bauer H.M., Packel L., Rhew M., Baxter R., et al. An observational cohort study of Chlamydia trachomatis treatment in pregnancy. Sex Transm Dis 2006; 33: 106 - 10.

31. Brocklehurst P., Rooney G. Interventions for treating genital chlamydia trachomatis infection in pregnancy. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD000054. DOI: 10.1002/14651858.CD000054.

32. Soltz-Szots J., Schneider S., Niebauer B., Knobler R.M., Lindmaier A. Significance of the dose of josamycin in the treatment of chlamydia infected pregnant patients. Z Hautkr 1989; 64: 129 - 31.

33. Галимова Э.Р. Опыт лечения хламидийной урогенитальной инфекции у беременных вильпрафеном. Актуальные вопросы акушерства и гинекологии 2001 - 2002; 1(1).

34. Darville T. Chlamydia trachomatis infections in neonates and young children. Semin Pediatr Infect Dis 2005; 16: 235 - 44.

35. Wang Y., Yang W.B., Yuan H.Y., Zhang Q.X., Zhu X.Y. Analysis of the infection status and the drug resistance of mycoplasma and chlamydiae in genitourinary tracts of children with suspected nongonococcal urethritis. Zhonghua Er Ke Za Zhi. 2009 Jan; 47(1): 62 - 4.

36. Ведение больных с инфекциями, передаваемыми половым путем, и урогенитальными инфекциями: Клинические рекомендации. Российское общество дерматовенерологов и косметологов. - М.: Деловой экспресс, 2012: 112 с.

37. Hammerschlag M.R., Gelling M., Roblin P.M., Kutlin A., Jule J.E. Treatment of neonatal chlamydial conjunctivitis with azithromycin. The Pediatric infectious disease journal. Nov 1998; 17(11): 1049 - 1050.

38. Kohlhoff C.A., Hammerschlag M.R. Treatment of chlamydial infections: 2014 update (review). Expert Opin. Pharmacother. (2015) 16 (2): 205 - 212.

39. Sexually Transmitted Diseases Treatment Guidelines 2015: Chlamydial Infections. CDC.

40. Mikamo H., Yamagishi Y., Takahashi K., et al. Clinical study of levofloxacin 500 mg qd in the treatment of cervicitis and intrauterine infections caused by Chlamydia trachomatis. Jpn J Antibiot. 2011 Aug; 64(4): 217 - 29.

41. Кубанов А.А., Богданова Е.В. Организация и результаты оказания медицинской помощи по профилю "дерматовенерология" в Российской Федерации. Итоги 2018 года. - Вестник дерматологии и венерологии. - Том 95. - N 4. - С. 8 - 23.

42. Landers D.V., Sweet R.L. Current trends in the diagnosis and treatment of tuboovarian abscess//Am. J. Obstet. Gynecol. - 1985. - Vol. 151. - P. 1098 - 1110. (диагностика тубоовариального абсцесса при осложненных формах ВЗОМТ).

43. Moore K.R., Smith J.S., Cole S.R., Dittmer D.P., Schoenbach V.J., Baird D.D. Chlamydia trachomatis Seroprevalence and Ultrasound-Diagnosed Uterine Fibroids in a Large Population of Young African-American Women. Am J Epidemiol. 2018; 187(2): 278 - 286. doi:10.1093/aje/kwx231.

44. Honkila M., Wikstrom E., Renko M., et al. Probability of vertical transmission of Chlamydia trachomatis estimated from national registry data. Sex Transm Infect. 2017; 93(6): 416 - 420. doi: 10.1136/sextrans-2016-052884 (B2).

45. Бекарова А.М. Хламидийная инфекция у новорожденных и детей первого года жизни. Диссертация на соискание ученой степени кандидата медицинских наук, 2003 г.

46. Виноградова И.В. "Эпидемиология, диагностические критерии и течение хламидийной инфекции у новорожденных детей", диссертация на соискание ученой степени кандидата медицинских наук, 2004 г.

47. П.В. Буданов. Актуальные проблемы лечения беременных с рецидивирующей хламидийной инфекцией. Лечащий врач. N 10/07.

48. Paez-Canro C., Alzate J.P., Gonzalez L.M., Rubio-Romero J.A., Lethaby A., Gaitan H.G.. Antibiotics for treating urogenital Chlamydia trachomatis infection in men and non-pregnant women. Cochrane Database Syst Rev. 2019; 1(1): CD010871. Published 2019 Jan 25. doi: 10.1002/14651858.CD010871.pub2.

49. William M. Geisler, Apurva Uniyal, Jeannette Y. Lee, Shelly Y. Lensing, Shacondra Johnson, Raymond C.W. Perry, Carmel M. Kadrnka and Peter R. Kerndt. Azithromycin versus Doxycycline for Urogenital Chlamydia trachomatis Infection. N Engl J Med 2015; 373: 2512 - 2521 DOI: 10.1056/NEJMoa1502599.

50. WHO Guidelines for the Treatment of Chlamydia trachomatis. 2016. URL: https://www.ncbi.nlm.nih.gov/books/NBK379707/pdf/Bookshelf_NBK379707.pdf.

51. Nicole H.T.M. Dukers-Muijrers, Petra F.G. Wolffs, Henry De Vries, Hannelore M. Gotz, Titia Heijman, Sylvia Bruisten, Lisanne Eppings, Arjan Hogewoning, Mieke Steenbakkers, Mayk Lucchesi, Maarten F. Schim van der Loeff, Christian J.P.A. Hoebe, Treatment Effectiveness of Azithromycin and Doxycycline in Uncomplicated Rectal and Vaginal Chlamydia trachomatis Infections in Women: A Multicenter Observational Study (FemCure), Clinical Infectious Diseases, Volume 69, Issue 11, 1 December 2019, Pages 1946 - 1954, https://doi.org/10.1093/cid/ciz050

52. KARL E. MILLER/Diagnosis and Treatment of Chlamydia trachomatis Infection. Am Fam Physician. 2006 Apr 15; 3(8): 1411 - 1416.

53. Geisler W.M., Koltun W.D., Abdelsayed N., et al. Safety and efficacy of WC2031 versus vibramycin for the treatment of uncomplicated urogenital Chlamydia trachomatis infection: a randomized, double-blind, double-dummy, active-controlled, multicenter trial. Clin Infect Dis 2012; 55: 82 - 8.

54. Takahashi S., Ichihara K., Hashimoto J., et al. Clinical efficacy of levofloxacin 500 mg once daily for 7 days for patients with nongonococcal urethritis. J Infect Chemother 2011; 17: 392 - 6.

55. E. Lanjouw, J.M. Ossewaarde, A. Stary, F. Boag. European guideline for the management of Chlamydia trachomatis infections. 2010. URL: https://www.aslimnica.lv/sites/default/files/editor/euro_guideline_chlamydia_2010.pdf.

56. Carter J.D. and Hudson A.P. The evolving story of Chlamydia-induced reactive arthritis. Curr Opin Rheumatol 2010; 22: 424 - 430; Taylor-Robinson D. and Keat A. Observations on Chlamydia trachomatis and other microbes in reactive arthritis. Int J STD AIDS 2015; 26: 139 - 144.

57. Bojovic J., Strelic N. and Pavlica L. Reiter's syndrome - disease of young men - analysis of 312 patients. Med Pregl 2014; 67: 222 - 230.44.

58. CDC 2015 Sexually transmitted infections treatment guidelines. Pelvic Inflammatory Disease. URL. https://www.cdc.gov/std/tg2015/pid.htm.

59. Ю.Б. Белоусов, О.И. Карпов, Д.Ю. Белоусов. Клинико-экономическое обоснование применения вильпрафена в лечении урогенитального хламидиоза. Качественная клиническая практика 2006 N 1.

60. Tan A.K. Ophthalmia Neonatorum. N Engl J Med. 2019 Jan 10; 380(2): e2. doi: 0.1056/NEJMicm1808613.

61. Jin J. Prevention of Gonococcal Eye Infection in Newborns. JAMA. 2019 Jan 29; 321(4): 414. doi: 10.1001/jama.2018.21434.

62. Zikic A. et al. Treatment of neonatal chlamydial conjunctivitis: A systematic review and meta-analysis//Journal of the Pediatric Infectious Diseases Society. - 2018. - T. 7. - N. 3. - С. e107 - e115.

63. European guideline for the management of Chlamydia trachomatis infections. Revision date: July 2010. (E. Lanjouw, J.M. Ossewaarde, A. Stary, F. Boag).

64. European Branch of the International Union against Sexually Transmitted Infections (IUSTI Europe) and the European Office of the World Health Organisation (WHO-Europe).

65. Савенкова М.С., Афанасьева А.А. Хламидиоз у детей. Современные аспекты лечения. Клиническая эффективность. с. 6 - 12. URL: https://www.umedp.ru/upload/iblock/e23/e23ac6fa5ddf584bd9e2be92049f3090.pdf.

66. Kimberly A. Workowski, Mary F. Lampe, Kim G. Wong; et al Mary B. Watts, Walter E. Stamm, Long-term Eradication of Chlamydia trachomatis Genital Infection After Antimicrobial Therapy Evidence Against Persistent Infection. JAMA. 1993; 270(17): 2071 - 2075. doi: 10.1001/jama.1993.03510170061031.

67. Урогенитальный хламидиоз. Учебное пособие 2014. Под редакцией д.м.н., профессора А.В. Молочкова, к.м.н. С.В. Муракова, д.м.н., профессора С.А. Попкова. ISBN 978-5-98511-256-6.

68. Gradison M. Pelvic Inflammatory Diseases. American Academy of Family Physicians. - 2012.

69. ВЗОМТ: Роль хламидийной инфекции (рациональные методы терапии) Информационный материал подготовлен д.м.н. Л.А. Марченко и к.м.н. Л.М. Ильиной 2006 г. по данным официальных рекомендаций Centers for Disease Control and Prevention (CDC), 2002 г.; статьи В.И. Кулакова А.С. Анкирской, С.М. Белобородова в ж. Гинекология (экстра-выпуск: "Современная ЭРА терапии инфекций в гинекологии"), 2004; MMWR 2004 (53) 42: 983; WebMDHealthNews, 2005 г.

70. Молчоков А.В. Урогенитальный хламидиоз. Учебное пособие Москва 2014.

71. Е.И. Боровкова. Современные стандарты терапии инфекций, передаваемых половым путем. Медицинский совет 2014 N 11.